TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $281,744 (100.0% shares, 0.0% debt)

Holdings (5)

HRTX HERON THERAPEUTICS INC 42.5%

Value ($000) $119,716 Shares 8,643,739 Est. Cost $13.92 Unrealized +4.1%

— LA JOLLA PHARMACEUTICAL CO 36.4%

Value ($000) $102,421 Shares 3,440,419 Est. Cost $16.25 Unrealized —

— IGNYTA INC 17.5%

Value ($000) $49,303 Shares 4,763,602 Est. Cost $6.25 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 2.9%

Value ($000) $8,193 Shares 90,215 Est. Cost $62.32 Unrealized +46.0%

— CYCLACEL PHARMACEUTICALS INC 0.7%

Value ($000) $2,111 Shares 559,900 Est. Cost $5.17 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	8,643,739	$119,716	42.5%	$13.92	+4.1%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	3,440,419	$102,421	36.4%	$16.25	—	COM	503459604
—	IGNYTA INC	4,763,602	$49,303	17.5%	$6.25	—	COM	451731103
BMRN	BIOMARIN PHARMACEUTICAL INC	90,215	$8,193	2.9%	$62.32	+46.0%	COM	09061G101
—	CYCLACEL PHARMACEUTICALS INC	559,900	$2,111	0.7%	$5.17	—	COM	23254L405